Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1352945-74-4

Post Buying Request

1352945-74-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1352945-74-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1352945-74-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,5,2,9,4 and 5 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1352945-74:
(9*1)+(8*3)+(7*5)+(6*2)+(5*9)+(4*4)+(3*5)+(2*7)+(1*4)=174
174 % 10 = 4
So 1352945-74-4 is a valid CAS Registry Number.

1352945-74-4Downstream Products

1352945-74-4Relevant articles and documents

Novel one pot synthesis of substituted quinazolin-4(3H)-ones and pyrazolo[4,3-d]pyrimidin-7(6H)-ones using copper iodide, azides and terminal alkynes

Srishyalam,Devanna,Basaveswara Rao,Mulakayala, Naveen

, p. 2889 - 2892 (2017)

A simple and highly efficient copper iodide catalyzed one-pot synthesis of 2-substituted quinazolin-4(3H)-ones have been developed from anthranilamide, terminal alkynes and azides. A wide variety of alkynes were screened to understand the scope of this methodology. This method has been extended for the synthesis of 5-substituted pyrazolo[4,3-d]pyrimidin-7(6H)-ones which are having potential applications in medicinal chemistry.

Exploiting interkingdom interactions for development of small-molecule inhibitors of candida albicans biofilm formation

Reen, F. Jerry,Phelan, John P.,Gallagher, Lorna,Woods, David F.,Shanahan, Rachel M.,Cano, Rafael,Muimhneacháin, Eoin ó,McGlacken, Gerard P.,O'Gara, Fergal

, p. 5894 - 5905 (2016)

A rapid decline in the development of new antimicrobial therapeutics has coincided with the emergence of new and more aggressive multidrug-resistant pathogens. Pathogens are protected from antibiotic activity by their ability to enter an aggregative biofilm state. Therefore, disrupting this process in pathogens is a key strategy for the development of next-generation antimicrobials. Here, we present a suite of compounds, based on the Pseudomonas aeruginosa 2-heptyl-4(1H)-quinolone (HHQ) core quinolone interkingdom signal structure, that exhibit noncytotoxic antibiofilm activity toward the fungal pathogen Candida albicans. In addition to providing new insights into what is a clinically important bacterium-fungus interaction, the capacity to modularize the functionality of the quinolone signals is an important advance in harnessing the therapeutic potential of signaling molecules in general. This provides a platform for the development of potent next-generation small-molecule therapeutics targeting clinically relevant fungal pathogens.

The cascade synthesis of quinazolinones and quinazolines using an α-MnO2 catalyst and tert-butyl hydroperoxide (TBHP) as an oxidant

Zhang, Zhe,Wang, Min,Zhang, Chaofeng,Zhang, Zhixin,Lu, Jianmin,Wang, Feng

supporting information, p. 9205 - 9207 (2015/06/02)

Heterogeneously catalyzed synthesis of quinazolinones or quinazolines is reported in this study. An α-MnO2 catalyst is found to be highly active and selective in the oxidative cyclization of anthranilamides or aminobenzylamines with alcohols using TBHP as an oxidant. This protocol exhibits a broad substrate scope, and is operationally simple without an additive.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1352945-74-4